DRUGMAX - das knallt gut!!!!!!!!!!! - 500 Beiträge pro Seite
eröffnet am 20.03.00 19:21:58 von
neuester Beitrag 19.02.02 20:20:39 von
neuester Beitrag 19.02.02 20:20:39 von
Beiträge: 6
ID: 99.128
ID: 99.128
Aufrufe heute: 0
Gesamt: 237
Gesamt: 237
Aktive User: 0
ISIN: US2622401048
Feedback
Das ist eine Chance! B2B - spezialisiert auf Medikamente!
Story ist gut - wird mit großer Wahrscheinlichkeit ein Hype!
Business-to-business Internet stocks have been on fire during the past year, with many rising more than tenfold in price. B2B stocks such as VerticalNet (Nasdaq: VERT), Commerce One (Nasdaq: CMRC) and Internet Capital Group (Nasdaq: ICGE) have all surged more than 15-fold since their initial public offerings last year and now sport market caps ranging from $8 to $28 billion.
However, we`ve discovered a little-known B2B stock with the potential for gains of 500 percent or more in the next 12 months: Drugmax.com (Nasdaq: DMAX), an online business-to-business trade exchange for companies in the pharmaceutical, over-the-counter, health and beauty care, and nutritional supplement industries.
Drugmax`s website (http://www.DrugMax.com) currently features auctions, a wholesale marketplace, classified ads and, in the near future, reverse auctions. Since its December 1999 launch, the Drugmax.com website is off to a strong start, with rapidly growing sales and nearly 1,000 pharmacies signing up to use the service
But it`s important to note that Drugmax.com isn`t starting from scratch, unlike many other companies attempting to create online business-to-business trade exchanges. Drugmax.com is currently on pace to tally more than $60 million in offline business-to-business sales for the fiscal year ending March 31, 2000 -- up 100 percent from the previous year. Drugmax.com is leveraging this significant revenue and customer base in order to help grow its online B2B trade exchange.
So why have online business-to-business companies been so hot lately? The answer is that when companies do business with other companies over the Internet via a specialized intermediary, such as Drugmax.com for the pharmaceutical industry, companies can save significant time while also obtaining better prices. In many industries, the estimated savings range from 10 to 20 percent. B2B companies, then, help businesses increase their profits.
For example, rather than spending hours or days calling around for prices on a product or service, a company can go to an appropriate B2B website for its industry and solicit bids from sellers or choose from sellers` existing offers. Either way, the company quickly gets access to many sellers without having to call them all, and it might get a better price too. And for sellers of products or services, the B2B website gives them access to many buyers without having to search for them, and can even help them unload surplus inventory at higher prices than they`d otherwise receive.
Forrester Research estimates that B2B e-commerce will grow from $43 billion in 1998 to $1.3 trillion by 2003, compared to just $108 billion for online business-to-consumer transactions in 2003. And Deloitte Consulting LLC says that 91 percent of U.S. businesses could do their purchasing on the net by the end of next year, up from 31 percent today.
Striving to become the premier B2B company in its industry, Drugmax.com is actively pursuing strategic alliances and acquisitions. The first major alliance was signed with PurchasePro.com in December. Under a strategic revenue sharing agreement, Drugmax.com will be the first pharmaceutical industry website to offer PurchasePro.com`s browser-based e-marketplace solution. This will allow Drugmax.com to provide a more complete e-commerce solution to the industry, increasing the benefits to its customers. The two companies will share the transaction revenue from this e-marketplace. PurchasePro.com was issued warrants to purchase 200,000 shares of Drugmax.com common stock, giving them further incentive to help Drugmax.com succeed.
As for strategic acquisitions, Drugmax.com recently signed a letter of intent to acquire Desktop Corp., a business-to-business technology incubator. Desktop is also a leading Internet e-commerce solutions company, specializing in the design, development and delivery of leading-edge technology solutions for e-commerce business. The corporation is a Microsoft Solutions Partner, with clients such as Citicorp, Fidelity Investments and J.C. Penney.
The Desktop acquisition also gives Drugmax.com a majority interest in VetMall.com, which is attempting to become the leading business-to-business Internet portal for the animal health industry. W.A. Butler Company, a major distributor of animal health and related products to veterinarians, owns the remaining interest in VetMall.com, giving Drugmax.com an excellent partner in making the site a success. VetMall.com currently provides web sites to over 22,000 veterinarians, sells over 3,500 consumer products, and has a registered membership of over 1,900 veterinary clinics.
VetMall.com`s plan is to give veterinarians their own web site which includes information about their clinic as well as a VetMall storefront with thousands of animal products for sale. When the veterinarian promotes this web site to his clients, and the clients buy products from the site, both the vet and VetMall.com get a percentage of the sale. If enough vets promote their VetMall sites, the sales on VetMall.com could prove enormous. And once vets start using VetMall for this service, it will be easier to gain their business for the services and supplies they need to run their clinic. Clearly, Drugmax.com`s acquisition of Desktop and VetMall.com has incredible potential.
Drugmax.com`s financial situation is strong, sporting about $8 million in cash, $15 million in current assets and only $5.7 million in liabilities. In November 1999, Drugmax.com raised more than $12 million through a public offering of shares at $10. The company currently has a letter of intent for an even larger offering of preferred stock, which will give the company the money it needs to continue developing its B2B trade exchange and make it the premier site for its industry.
DMAX stock remains cheap compared to other B2B stocks. Drugmax.com`s current market cap totals some $100 million, compared to market caps in the billions for many business-to-business stocks. eMerge Interactive (Nasdaq: EMRG), another company that offers B2B services to a single industry -- the cattle industry, in this case -- has a market cap of approximately $1.8 billion. Even if DMAX shares surged to $100, its market cap still would fall shy of $1 billion.
We believe DMAX shares are worth serious consideration from risk tolerant smallcap investors interested in the huge potential of B2B stocks. As DrugMax.com continues to develop and grow, and investors and funds start to become aware of the company, DMAX shares could move sharply higher. Our 12-month price target is $100, with the potential to move much higher. Considering the significant upside potential in this stock, DMAX shares appear extremely attractive at their current price
Story ist gut - wird mit großer Wahrscheinlichkeit ein Hype!
Business-to-business Internet stocks have been on fire during the past year, with many rising more than tenfold in price. B2B stocks such as VerticalNet (Nasdaq: VERT), Commerce One (Nasdaq: CMRC) and Internet Capital Group (Nasdaq: ICGE) have all surged more than 15-fold since their initial public offerings last year and now sport market caps ranging from $8 to $28 billion.
However, we`ve discovered a little-known B2B stock with the potential for gains of 500 percent or more in the next 12 months: Drugmax.com (Nasdaq: DMAX), an online business-to-business trade exchange for companies in the pharmaceutical, over-the-counter, health and beauty care, and nutritional supplement industries.
Drugmax`s website (http://www.DrugMax.com) currently features auctions, a wholesale marketplace, classified ads and, in the near future, reverse auctions. Since its December 1999 launch, the Drugmax.com website is off to a strong start, with rapidly growing sales and nearly 1,000 pharmacies signing up to use the service
But it`s important to note that Drugmax.com isn`t starting from scratch, unlike many other companies attempting to create online business-to-business trade exchanges. Drugmax.com is currently on pace to tally more than $60 million in offline business-to-business sales for the fiscal year ending March 31, 2000 -- up 100 percent from the previous year. Drugmax.com is leveraging this significant revenue and customer base in order to help grow its online B2B trade exchange.
So why have online business-to-business companies been so hot lately? The answer is that when companies do business with other companies over the Internet via a specialized intermediary, such as Drugmax.com for the pharmaceutical industry, companies can save significant time while also obtaining better prices. In many industries, the estimated savings range from 10 to 20 percent. B2B companies, then, help businesses increase their profits.
For example, rather than spending hours or days calling around for prices on a product or service, a company can go to an appropriate B2B website for its industry and solicit bids from sellers or choose from sellers` existing offers. Either way, the company quickly gets access to many sellers without having to call them all, and it might get a better price too. And for sellers of products or services, the B2B website gives them access to many buyers without having to search for them, and can even help them unload surplus inventory at higher prices than they`d otherwise receive.
Forrester Research estimates that B2B e-commerce will grow from $43 billion in 1998 to $1.3 trillion by 2003, compared to just $108 billion for online business-to-consumer transactions in 2003. And Deloitte Consulting LLC says that 91 percent of U.S. businesses could do their purchasing on the net by the end of next year, up from 31 percent today.
Striving to become the premier B2B company in its industry, Drugmax.com is actively pursuing strategic alliances and acquisitions. The first major alliance was signed with PurchasePro.com in December. Under a strategic revenue sharing agreement, Drugmax.com will be the first pharmaceutical industry website to offer PurchasePro.com`s browser-based e-marketplace solution. This will allow Drugmax.com to provide a more complete e-commerce solution to the industry, increasing the benefits to its customers. The two companies will share the transaction revenue from this e-marketplace. PurchasePro.com was issued warrants to purchase 200,000 shares of Drugmax.com common stock, giving them further incentive to help Drugmax.com succeed.
As for strategic acquisitions, Drugmax.com recently signed a letter of intent to acquire Desktop Corp., a business-to-business technology incubator. Desktop is also a leading Internet e-commerce solutions company, specializing in the design, development and delivery of leading-edge technology solutions for e-commerce business. The corporation is a Microsoft Solutions Partner, with clients such as Citicorp, Fidelity Investments and J.C. Penney.
The Desktop acquisition also gives Drugmax.com a majority interest in VetMall.com, which is attempting to become the leading business-to-business Internet portal for the animal health industry. W.A. Butler Company, a major distributor of animal health and related products to veterinarians, owns the remaining interest in VetMall.com, giving Drugmax.com an excellent partner in making the site a success. VetMall.com currently provides web sites to over 22,000 veterinarians, sells over 3,500 consumer products, and has a registered membership of over 1,900 veterinary clinics.
VetMall.com`s plan is to give veterinarians their own web site which includes information about their clinic as well as a VetMall storefront with thousands of animal products for sale. When the veterinarian promotes this web site to his clients, and the clients buy products from the site, both the vet and VetMall.com get a percentage of the sale. If enough vets promote their VetMall sites, the sales on VetMall.com could prove enormous. And once vets start using VetMall for this service, it will be easier to gain their business for the services and supplies they need to run their clinic. Clearly, Drugmax.com`s acquisition of Desktop and VetMall.com has incredible potential.
Drugmax.com`s financial situation is strong, sporting about $8 million in cash, $15 million in current assets and only $5.7 million in liabilities. In November 1999, Drugmax.com raised more than $12 million through a public offering of shares at $10. The company currently has a letter of intent for an even larger offering of preferred stock, which will give the company the money it needs to continue developing its B2B trade exchange and make it the premier site for its industry.
DMAX stock remains cheap compared to other B2B stocks. Drugmax.com`s current market cap totals some $100 million, compared to market caps in the billions for many business-to-business stocks. eMerge Interactive (Nasdaq: EMRG), another company that offers B2B services to a single industry -- the cattle industry, in this case -- has a market cap of approximately $1.8 billion. Even if DMAX shares surged to $100, its market cap still would fall shy of $1 billion.
We believe DMAX shares are worth serious consideration from risk tolerant smallcap investors interested in the huge potential of B2B stocks. As DrugMax.com continues to develop and grow, and investors and funds start to become aware of the company, DMAX shares could move sharply higher. Our 12-month price target is $100, with the potential to move much higher. Considering the significant upside potential in this stock, DMAX shares appear extremely attractive at their current price
Für alle Lesefaulen - die Facts:
Company Name Drugmax.com, Inc.
Nasdaq symbol DMAX
Stock price (3-1-2000) $15.625 bid, $16.125 ask
52 Week Range low $6.25, high $26
Target Price $100
Shares Outstanding 6,076,707
Market Capitalization $100 million
Insider ownership 59%
Website http://www.Drugmax.com/
Company Name Drugmax.com, Inc.
Nasdaq symbol DMAX
Stock price (3-1-2000) $15.625 bid, $16.125 ask
52 Week Range low $6.25, high $26
Target Price $100
Shares Outstanding 6,076,707
Market Capitalization $100 million
Insider ownership 59%
Website http://www.Drugmax.com/
GOOD NEWS
Article for Drugmax Com Inc (NASDAQ SC
MAX)
7:15 AM
most recent headlines
next article:
Drugmax.com Announces Exclusive Pharmacy Distribution Rights for Industry`s First,
All-Natural Protein Snack Chip; $5-$7 Million in Additional Revenue Expected
MONDAY, JUNE 12, 2000 7:15 AM
- BusinessWire
LARGO, Fla., Jun 12, 2000 (BUSINESS WIRE) -- Drugmax.com (NasdaqMAX), the leading business-to-business
online trade exchange for pharmaceuticals, over-the-counter products, health and beauty aids, and nutritional
supplements, today announced that it has reached an agreement with Tampa, Fla.-based Breakthrough Engineered
Nutrition, Inc. to become the exclusive pharmacy distributor of new Lean Protein Snack Chips(tm). Drugmax.com is
taking pre-orders for the product on its Web site now, and product delivery will commence in July 2000.
Lean Protein Snack Chips(tm) serve as a healthy, all-natural snack, an excellent protein source for general
consumers and athletes, and also are a perfect choice for diabetics. Since Lean Protein Snack Chips(tm) have no
carbohydrates and no sugar, it does not impact a blood sugar or insulin levels. The snack chips, available in two
delicious flavors (Sour Cream & Onion, and Cool Ranch) provide a satisfying crunch, and are baked rather than fried
so there is no oily flavor. The world`s first no-carbohydrate, no-sugar dietary snack, Lean Protein Snack Chips(tm) are
the result of several years of nutritional research, and they provide a protein blend comprised of highly bio-available
soy and whey isolates.
"We are pleased to be able to offer this exciting new product to our roster of pharmacies and distributors," said Lori
Murphy, Drugmax.com Director of Sales. "The market for diet and nutrition products is estimated at $22 billion
annually, and protein-specific dietary supplements are particularly hot right now," she said. "Because of our broad
base of pharmacy customers, Drugmax.com allows vendors to launch new products more economically, quickly and
efficiently. In addition, the company`s ability to provide leading-edge products to pharmacies and health food stores
before the products hit the market elsewhere means these pharmacies will have a competitive advantage in driving
customers into their stores."
"Drugmax.com will greatly benefit from this distribution agreement," noted Drugmax.com CEO William LaGamba. "By
offering the only all-natural, protein-only snack chip on the market today, we foresee high-volume sales to both
pharmacies and health food stores, with estimated annual revenues of $5-$7 million from Breakthrough`s product line."
About Drugmax.com
Drugmax.com, Inc. is an Internet business-to-business trade exchange for pharmaceuticals, over-the-counter
products, health and beauty aids and nutritional supplements. Drugmax.com brings together retailers, manufacturers,
wholesalers and major end-users into a single, efficient marketplace for buying, selling, trading and industry news.
Except for the historical information contained herein, the matter discussed in this press release are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These forward-looking statements reflect assumptions and involve risk and uncertainties that may affect
Drugmax.com, Inc.`s business and prospects and cause actual results to differ materially from these forward-looking
statements.
About Breakthrough Engineered Nutrition, Inc.
Breakthrough Engineered Nutrition, Inc. is a company committed to the development, marketing and distribution of
all-natural, low and zero-carbohydrate food and dietary solutions. Breakthrough utilizes the most advanced technology
to develop products that satisfy the consumer`s need for functional foods that are both healthy and convenient.
GOOD CHART
mein ziel bis ende 2000
DAS ALTE HOCH bei 45 $
ciao
fecc
Article for Drugmax Com Inc (NASDAQ SC
MAX)7:15 AM
most recent headlines
next article:
Drugmax.com Announces Exclusive Pharmacy Distribution Rights for Industry`s First,
All-Natural Protein Snack Chip; $5-$7 Million in Additional Revenue Expected
MONDAY, JUNE 12, 2000 7:15 AM
- BusinessWire
LARGO, Fla., Jun 12, 2000 (BUSINESS WIRE) -- Drugmax.com (Nasdaq
MAX), the leading business-to-businessonline trade exchange for pharmaceuticals, over-the-counter products, health and beauty aids, and nutritional
supplements, today announced that it has reached an agreement with Tampa, Fla.-based Breakthrough Engineered
Nutrition, Inc. to become the exclusive pharmacy distributor of new Lean Protein Snack Chips(tm). Drugmax.com is
taking pre-orders for the product on its Web site now, and product delivery will commence in July 2000.
Lean Protein Snack Chips(tm) serve as a healthy, all-natural snack, an excellent protein source for general
consumers and athletes, and also are a perfect choice for diabetics. Since Lean Protein Snack Chips(tm) have no
carbohydrates and no sugar, it does not impact a blood sugar or insulin levels. The snack chips, available in two
delicious flavors (Sour Cream & Onion, and Cool Ranch) provide a satisfying crunch, and are baked rather than fried
so there is no oily flavor. The world`s first no-carbohydrate, no-sugar dietary snack, Lean Protein Snack Chips(tm) are
the result of several years of nutritional research, and they provide a protein blend comprised of highly bio-available
soy and whey isolates.
"We are pleased to be able to offer this exciting new product to our roster of pharmacies and distributors," said Lori
Murphy, Drugmax.com Director of Sales. "The market for diet and nutrition products is estimated at $22 billion
annually, and protein-specific dietary supplements are particularly hot right now," she said. "Because of our broad
base of pharmacy customers, Drugmax.com allows vendors to launch new products more economically, quickly and
efficiently. In addition, the company`s ability to provide leading-edge products to pharmacies and health food stores
before the products hit the market elsewhere means these pharmacies will have a competitive advantage in driving
customers into their stores."
"Drugmax.com will greatly benefit from this distribution agreement," noted Drugmax.com CEO William LaGamba. "By
offering the only all-natural, protein-only snack chip on the market today, we foresee high-volume sales to both
pharmacies and health food stores, with estimated annual revenues of $5-$7 million from Breakthrough`s product line."
About Drugmax.com
Drugmax.com, Inc. is an Internet business-to-business trade exchange for pharmaceuticals, over-the-counter
products, health and beauty aids and nutritional supplements. Drugmax.com brings together retailers, manufacturers,
wholesalers and major end-users into a single, efficient marketplace for buying, selling, trading and industry news.
Except for the historical information contained herein, the matter discussed in this press release are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These forward-looking statements reflect assumptions and involve risk and uncertainties that may affect
Drugmax.com, Inc.`s business and prospects and cause actual results to differ materially from these forward-looking
statements.
About Breakthrough Engineered Nutrition, Inc.
Breakthrough Engineered Nutrition, Inc. is a company committed to the development, marketing and distribution of
all-natural, low and zero-carbohydrate food and dietary solutions. Breakthrough utilizes the most advanced technology
to develop products that satisfy the consumer`s need for functional foods that are both healthy and convenient.
GOOD CHART
mein ziel bis ende 2000
DAS ALTE HOCH bei 45 $
ciao
fecc
nur noch geile news
HAMMER
Drugmax.com Launches Pharmaceutical Industry`s First ``Alternate Supply`` Electronic
Exchange
THURSDAY, AUGUST 10, 2000 8:54 AM
- BusinessWire
LARGO, Fla., Aug 10, 2000 (BUSINESS WIRE) --
Drugmax First in Pharmaceutical Industry to Launch Full Array of
On-Line Services; Expands Company Focus, Revenue Opportunities
Drugmax.com (NasdaqMAX), the leading business-to-business online trade exchange for pharmaceuticals,
over-the-counter products, health and beauty aids, and nutritional supplements, today announced the launch of
DrugmaxTrading.com -- a new online business-to-business exchange aimed at pharmaceutical manufacturers,
wholesalers, retailers and distributors. DrugmaxTrading.com, which will function as a division of Drugmax.com,
launched its operations today and is based on proprietary technology developed by Drugmax.com engineers.
Drugmax.com is pursuing this new e-commerce venture because of the tremendous opportunities posed by this $30
billion per year industry, according to Drugmax.com President Bill LaGamba. "Currently, this market is very
fragmented," he said. "In providing a full-service, one-stop venue, we will be providing a major leap forward in managing
operations for manufacturers, wholesalers, retailers and distributors. DrugmaxTrading.com will become the industry`s
main electronic community for these sources, and we will generate additional revenues from coordinating
transactions."
DrugmaxTrading.com will feature three key components; each designed to provide significant economies of scale for
buyers and sellers. The first component is a "Best Buy System" which includes an online catalog of pharmaceuticals,
over-the-counter products, health and beauty aids, and nutritional supplements. Product Information is uploaded into
the Drugmax database by multiple vendors, and a corresponding system that automatically searches for the desired
product and provides information on where to obtain the lowest price.
The second component is a Closeout/short-dated section, where products that are approaching expiration but are still
viable will be offered. Based on the expiration date, the price of the product will decrease daily as the expiration date
approaches.
The third component is a new auction component that will function exclusively for manufacturers, distributors,
wholesalers and retailers, rather than consumers. These audiences will have the opportunity to participate in auctions
as inventory is posted for sale.
"DrugmaxTrading.com is a logical extension of Drugmax.com`s successful work in providing e-commerce options for
small and independent pharmacies and regional chains," noted LaGamba. "In launching this new e-commerce venue,
we will gain access to a vastly expanded array of transactions, expanding our reach in the pharmaceutical industry
and our revenue streams."
ES MUß KNALLEN
bye
andy
HAMMER
Drugmax.com Launches Pharmaceutical Industry`s First ``Alternate Supply`` Electronic
Exchange
THURSDAY, AUGUST 10, 2000 8:54 AM
- BusinessWire
LARGO, Fla., Aug 10, 2000 (BUSINESS WIRE) --
Drugmax First in Pharmaceutical Industry to Launch Full Array of
On-Line Services; Expands Company Focus, Revenue Opportunities
Drugmax.com (Nasdaq
MAX), the leading business-to-business online trade exchange for pharmaceuticals,over-the-counter products, health and beauty aids, and nutritional supplements, today announced the launch of
DrugmaxTrading.com -- a new online business-to-business exchange aimed at pharmaceutical manufacturers,
wholesalers, retailers and distributors. DrugmaxTrading.com, which will function as a division of Drugmax.com,
launched its operations today and is based on proprietary technology developed by Drugmax.com engineers.
Drugmax.com is pursuing this new e-commerce venture because of the tremendous opportunities posed by this $30
billion per year industry, according to Drugmax.com President Bill LaGamba. "Currently, this market is very
fragmented," he said. "In providing a full-service, one-stop venue, we will be providing a major leap forward in managing
operations for manufacturers, wholesalers, retailers and distributors. DrugmaxTrading.com will become the industry`s
main electronic community for these sources, and we will generate additional revenues from coordinating
transactions."
DrugmaxTrading.com will feature three key components; each designed to provide significant economies of scale for
buyers and sellers. The first component is a "Best Buy System" which includes an online catalog of pharmaceuticals,
over-the-counter products, health and beauty aids, and nutritional supplements. Product Information is uploaded into
the Drugmax database by multiple vendors, and a corresponding system that automatically searches for the desired
product and provides information on where to obtain the lowest price.
The second component is a Closeout/short-dated section, where products that are approaching expiration but are still
viable will be offered. Based on the expiration date, the price of the product will decrease daily as the expiration date
approaches.
The third component is a new auction component that will function exclusively for manufacturers, distributors,
wholesalers and retailers, rather than consumers. These audiences will have the opportunity to participate in auctions
as inventory is posted for sale.
"DrugmaxTrading.com is a logical extension of Drugmax.com`s successful work in providing e-commerce options for
small and independent pharmacies and regional chains," noted LaGamba. "In launching this new e-commerce venue,
we will gain access to a vastly expanded array of transactions, expanding our reach in the pharmaceutical industry
and our revenue streams."
ES MUß KNALLEN
bye
andy
http://biz.yahoo.com/bw/010615/2103.html
Revenues were approximately $177.7 million for the year ended March 31, 2001, a 744 percent increase over the $21 million for the fiscal year ended March 31, 2000. Revenues were approximately $55.2 million for the fourth quarter ended March 31, 2001 compared to $13.8 million for the fourth quarter ended March 31, 2000, a 300 percent increase.
744% Steigerung
Das ist gut
Gruß
Revenues were approximately $177.7 million for the year ended March 31, 2001, a 744 percent increase over the $21 million for the fiscal year ended March 31, 2000. Revenues were approximately $55.2 million for the fourth quarter ended March 31, 2001 compared to $13.8 million for the fourth quarter ended March 31, 2000, a 300 percent increase.
744% Steigerung
Das ist gut
Gruß
Trading Spotlight
Wie weit wollen die den Kurs noch drücken, bis Sie wieder
ein paar zehntausend Stück einsacken?
Haben die Ihr Ziel erreicht, dann wird der Kurs nach oben
gedrückt.
Noch ist Zeit zum Kauf, wer weiß wie lange noch? Hier sind locker ein paar 100% drin!
Wer ist noch meiner Meinung zu Drugmax, oder kann etwas
sinnvolles dazu äußern?
ein paar zehntausend Stück einsacken?
Haben die Ihr Ziel erreicht, dann wird der Kurs nach oben
gedrückt.
Noch ist Zeit zum Kauf, wer weiß wie lange noch? Hier sind locker ein paar 100% drin!
Wer ist noch meiner Meinung zu Drugmax, oder kann etwas
sinnvolles dazu äußern?
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -4,13 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 174 | ||
| 68 | ||
| 51 | ||
| 35 | ||
| 33 | ||
| 31 | ||
| 30 | ||
| 21 | ||
| 21 | ||
| 17 |
